713 related articles for article (PubMed ID: 28611215)
21. Genome-wide CRISPR-Cas9 Interrogation of Splicing Networks Reveals a Mechanism for Recognition of Autism-Misregulated Neuronal Microexons.
Gonatopoulos-Pournatzis T; Wu M; Braunschweig U; Roth J; Han H; Best AJ; Raj B; Aregger M; O'Hanlon D; Ellis JD; Calarco JA; Moffat J; Gingras AC; Blencowe BJ
Mol Cell; 2018 Nov; 72(3):510-524.e12. PubMed ID: 30388412
[TBL] [Abstract][Full Text] [Related]
22. Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data.
Feng H; Li T; Zhang X
BMC Genomics; 2018 Aug; 19(Suppl 6):564. PubMed ID: 30367578
[TBL] [Abstract][Full Text] [Related]
23. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells.
Wei C; Wang F; Liu W; Zhao W; Yang Y; Li K; Xiao L; Shen J
Mol Med Rep; 2018 Feb; 17(2):2901-2906. PubMed ID: 29257308
[TBL] [Abstract][Full Text] [Related]
26. Generation of PTEN‑knockout (‑/‑) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling.
Takao A; Yoshikawa K; Karnan S; Ota A; Uemura H; De Velasco MA; Kura Y; Suzuki S; Ueda R; Nishino T; Hosokawa Y
Oncol Rep; 2018 Nov; 40(5):2455-2466. PubMed ID: 30226608
[TBL] [Abstract][Full Text] [Related]
27. Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression.
Lee AR; Li Y; Xie N; Gleave ME; Cox ME; Collins CC; Dong X
Oncotarget; 2017 Apr; 8(17):27966-27975. PubMed ID: 28427194
[TBL] [Abstract][Full Text] [Related]
28. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.
Gu L; Frommel SC; Oakes CC; Simon R; Grupp K; Gerig CY; Bär D; Robinson MD; Baer C; Weiss M; Gu Z; Schapira M; Kuner R; Sültmann H; Provenzano M; ; Yaspo ML; Brors B; Korbel J; Schlomm T; Sauter G; Eils R; Plass C; Santoro R
Nat Genet; 2015 Jan; 47(1):22-30. PubMed ID: 25485837
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway.
Xiong W; Huang C; Deng H; Jian C; Zen C; Ye K; Zhong Z; Zhao X; Zhu L
Int J Biochem Cell Biol; 2018 Jan; 94():125-132. PubMed ID: 29225160
[TBL] [Abstract][Full Text] [Related]
30. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
Fujinami K; Uemura H; Ishiguro H; Kubota Y
Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
[TBL] [Abstract][Full Text] [Related]
31. Conserved role of hnRNPL in alternative splicing of epigenetic modifiers enables B cell activation.
Subramani PG; Fraszczak J; Helness A; Estall JL; Möröy T; Di Noia JM
EMBO Rep; 2024 Jun; 25(6):2662-2697. PubMed ID: 38744970
[TBL] [Abstract][Full Text] [Related]
32. The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.
Brizzolara A; Benelli R; Venè R; Barboro P; Poggi A; Tosetti F; Ferrari N
Cancer Lett; 2017 Aug; 400():9-17. PubMed ID: 28450158
[TBL] [Abstract][Full Text] [Related]
33. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.
Salameh A; Lee AK; Cardó-Vila M; Nunes DN; Efstathiou E; Staquicini FI; Dobroff AS; Marchiò S; Navone NM; Hosoya H; Lauer RC; Wen S; Salmeron CC; Hoang A; Newsham I; Lima LA; Carraro DM; Oliviero S; Kolonin MG; Sidman RL; Do KA; Troncoso P; Logothetis CJ; Brentani RR; Calin GA; Cavenee WK; Dias-Neto E; Pasqualini R; Arap W
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8403-8. PubMed ID: 26080435
[TBL] [Abstract][Full Text] [Related]
34. Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
Mäki HE; Saramäki OR; Shatkina L; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Cato AC; Visakorpi T
J Pathol; 2007 Aug; 212(4):395-401. PubMed ID: 17503439
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer.
Yin W; Chen J; Wang G; Zhang D
Mol Med Rep; 2019 Aug; 20(2):951-958. PubMed ID: 31173237
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis.
Marques Howarth M; Simpson D; Ngok SP; Nieves B; Chen R; Siprashvili Z; Vaka D; Breese MR; Crompton BD; Alexe G; Hawkins DS; Jacobson D; Brunner AL; West R; Mora J; Stegmaier K; Khavari P; Sweet-Cordero EA
J Clin Invest; 2014 Dec; 124(12):5275-90. PubMed ID: 25401475
[TBL] [Abstract][Full Text] [Related]
37. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells.
Ben Aicha S; Lessard J; Pelletier M; Fournier A; Calvo E; Labrie C
Physiol Genomics; 2007 Oct; 31(2):295-305. PubMed ID: 17712038
[TBL] [Abstract][Full Text] [Related]
39. Emerging roles of hnRNPA1 in modulating malignant transformation.
Roy R; Huang Y; Seckl MJ; Pardo OE
Wiley Interdiscip Rev RNA; 2017 Nov; 8(6):. PubMed ID: 28791797
[TBL] [Abstract][Full Text] [Related]
40. Characterization of drug-induced splicing complexity in prostate cancer cell line using long read technology.
Chen X; Houten S; Allette K; Sebra RP; Stolovitzky G; Losic B
Pac Symp Biocomput; 2018; 23():8-19. PubMed ID: 29218865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
